Elissa Hudspeth, M.S., is the assistant director of Downstream at BTEC. Her expertise is on downstream processing of biopharmaceuticals and supporting analytical assays, including gene therapies and vaccines.
At BTEC, Elissa teaches in the Analytical Methods for Gene Therapy short course and in the asynchronous online short course, Trends and Emerging Technologies in Downstream Biopharmaceutical Processing. She also supports other courses, including Hands-On cGMP Biomanufacturing Operations, Hands-On cGMP Biomanufacturing of Vectors for Gene Therapy, and Downstream Biopharmaceutical Processes: Fundamentals and Design.
Elissa has led the development of several downstream cGMP clinical and commercial processes at various BioPharm companies for over 10 years. These include cell and gene therapy processes at Novartis and Lonza as a Senior Manager and Scientist, respectively, and several recombinant protein vaccine processes at Texas Children’s Hospital Center for Vaccine Development. After getting her Masters of Science in Biotechnology, she also gained several years teaching experience at the University of Houston – Clear Lake.
She obtained a B.S. in Chemistry from the University of Southern Mississippi and an M.S. in Biotechnology from the University of Houston – Clear Lake, where her thesis work focused on protein crystallography.